Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04326192 · ClinicalTrials.gov registry record · NA

Brown Adipose Tissue Activation by Spinal Cord Stimulation

A NA study of Type 2 Diabetes and Obesity, Morbid, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04326192 is a NA study of Type 2 Diabetes and Obesity, Morbid that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 10 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04326192, a NA study of Type 2 Diabetes and Obesity, Morbid, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to investigate and utilize spinal cord stimulation (SCS) as an effective approach to eliciting weight loss and potentially alleviating Type 2 diabetes mellitus (DM), as evidenced by increasing metabolism of adipose tissue.

Interventions

  • DEVICE Research electrode

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-02-19
Est. Completion 2026-10
Phase NA

What the Registry Record Tells You About NCT04326192

The ClinicalTrials.gov registry entry for NCT04326192 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Research electrode is the first listed.

NCT04326192 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT04326192 about?

NCT04326192 is a clinical study titled "Brown Adipose Tissue Activation by Spinal Cord Stimulation". The objective of this study is to investigate and utilize spinal cord stimulation (SCS) as an effective approach to eliciting weight loss and potentially alleviating Type 2 diabetes mellitus (DM), as evidenced by increasing metabolism of adipose tissue.

What is the current status of trial NCT04326192?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2021-02-19. Estimated completion is 2026-10.

What conditions does trial NCT04326192 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Obesity, Morbid, Pain, Back.

What interventions are being tested in trial NCT04326192?

The interventions under investigation include: Research electrode (DEVICE).

Who is sponsoring clinical trial NCT04326192?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04326192 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.